CVRx | Barostim™ | Heart Failure Device Implant
CVRx offers a heart failure therapy option with Barostim™, the world’s first neuromodulation device for heart failure management. Learn more now!
Our Company | About Us - CVRx
CVRx ® advances health for people everywhere, giving each patient a fuller life. CVRx ® pioneers unique therapies that harness and harmonize the body’s natural systems, benefiting society and making CVRx ® a universal role model in healthcare.
CVRx, Inc. (CVRX) Stock Price, News, Quote & History - Yahoo Finance
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.
Carotid Baroreceptor Stimulation Device | Barostim™ - CVRx
Barostim is an option to improve exercise capacity in the 70% of patients not indicated for CRT. GDMT improves heart failure mortality and morbidity in HFrEF patients, but only shows modest improvement in exercise capacity. 1
FDA approves new device to improve symptoms in patients with advanced ...
The FDA granted approval of the Barostim Neo System to CVRx Inc. The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety ...
CVRx Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
3 days ago · CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the United States, Germany, and Other...
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 …
4 days ago · CVRx is focused on the development and commercialization of the Barostim™ System, the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. Baroreceptors activate ...
Congestive Heart Failure treatment - Barostim
Barostim is the world’s first FDA-approved neuromodulation system designed for Congestive Heart Failure treatment. Turn Heart Failure into Heart Success.
Investor Relations - CVRx
CVRx® is a leader in the development of safe and effective therapies to address unmet needs in cardiovascular disease. Headquartered near Minneapolis, Minn., CVRx is dedicated to improving patient outcomes, quality of life and overall cardiovascular health via our novel baroreceptor neuromodulation therapies.
CVRx (CVRX) Stock Price, News & Analysis - MarketBeat
3 days ago · CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart ...